277
Participants
Start Date
July 18, 2016
Primary Completion Date
November 20, 2017
Study Completion Date
November 20, 2017
natalizumab
Administered as specified in the treatment arm
Placebo
Matched placebo
Research Site, New York
Research Site, Girona
Research Site, Abington
Research Site, Durham
Research Site, Philadelphia
Research Site, Washington D.C.
Research Site, Hamburg
Research Site, Lugo
Research Site, Madrid
Research Site, Madrid
Research Site, Málaga
Research Site, Charleston
Research Site, Minden
Research Site, Gainesville
Research Site, Düsseldorf
Research Site, Seville
Research Site, Seville
Research Site, Columbus
Research Site, Fort Wayne
Research Site, Valladolid
Research Site, Münster
Research Site, Bergisch Gladbach
Research Site, Trier
Research Site, Frankfurt
Research Site, St Louis
Research Site, Ludwigshafen
Research Site, Mannheim
Research Site, Heidelberg
Research Site, Tübingen
Research Site, Ulm
Research Site, Los Angeles
Research Site, Erlangen
Research Site, San Diego
Research Site, Sacramento
Research Site, Bamberg
Research Site, Portland
Research Site, Portland
Research Site, Portland
Research Site, Bad Neustadt/Saale
Research Site, Boston
Research Site, Knoxville
Research Site, Altenburg
Research Site, Dresden
Research Site, Dresden
Research Site, Leipzig
Research Site, Albacete
Research Site, Badalona
Research Site, Barcelona
Research Site, Barcelona
Research Site, London
Research Site, London
Research Site, Harrow
Research Site, Stoke-on-Trent
Lead Sponsor
Biogen
INDUSTRY